跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 29,564 条关于
“Idylla™ EGFR Mutation Test”
全部
29,564
临床试验
21,785
药物
662
机构
107
资讯
7,010
去年
Biocartis Achieves First IVDR Class C Companion Diagnostic Certification for EGFR Mutation Test in Europe
3个月前
Agilus Diagnostics Launches Idylla System for Rapid Cancer Mutation Testing in Under 3 Hours
去年
Biocartis Receives FDA Approval for First Fully Automated Companion Diagnostic Test for Colorectal Cancer
去年
ctDNA Clearance Predicts Improved Outcomes in EGFR-Mutated NSCLC Treated with Icotinib
3个月前
Biocartis and City of Hope Partner to Develop Rapid Blood-Based Gene Signature Test for Early Pancreatic Cancer Detection
去年
Early CAR-T Vector Load Assessment Using Idylla Platform Shows Promise in Predicting LBCL Treatment Outcomes
去年
Lunit and AstraZeneca to Present AI Model for EGFR Mutation Prediction in NSCLC at AACR 2025
前天
BlossomHill's OMNI-EGFR Inhibitor BH-30643 Yields 45% ORR in C797S-Positive NSCLC
去年
Strategies Emerge to Combat Acquired Resistance in EGFR-Mutant NSCLC
去年
BlossomHill Therapeutics Advances EGFR-Mutant NSCLC Treatment with First-in-Class OMNI-EGFR Inhibitor BH-30643
第 1 页，共 701 页
上一页
下一页
